425-23 | A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Overview

“A Phase 1/2 Trial of Selinexor (KPT-330) and Radiation Therapy in Newly-Diagnosed Pediatric Diffuse Intrinsic Pontine Glioma (DIPG) and High-Grade Glioma (HGG)”

This is a study to see if a new medication called selinexor can help improve the survival of children with aggressive brain tumors called DIPG, DMG and other types of pediatric brain tumors. There tumors are very difficult to treat and have low long-term survival rates. Selinexor works by blocking a protein that helps tumors grow. In this study, children will receive selinexor along with radiation therapy, followed by selinexor as a maintenance therapy. We want to see if this combination can help children live longer and prevent the tumor from coming back.